Transarterial chemoembolization is a safe treatment for unresectable hepatic malignancies

American Surgeon

Volumn 63, Issue 10, 1997, Pages 923-926

  Lopez Jr , Richard R ^a   Pan, Shi Hui ^a   Lois, Juan F ^a   Mcmonigle, Michael E ^a   Hoffman, Allen L ^a   Sher, Linda S ^a   Lugo, Diana ^a   Makowka, Leonard ^a  

^a ST VINCENT MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; DOXORUBICIN; MITOMYCIN;

ADULT; AGED; ANOREXIA; ARTICLE; ARTIFICIAL EMBOLISM; ASCITES; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; FEMALE; FEVER; HOSPITALIZATION; HUMAN; INFECTION; INOPERABLE CANCER; INTRAARTERIAL DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER FAILURE; MALE; METASTASIS; NAUSEA; PAIN; VOMITING;

ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CARCINOID TUMOR; CARCINOMA, HEPATOCELLULAR; CHEMOEMBOLIZATION, THERAPEUTIC; CISPLATIN; DOXORUBICIN; EVALUATION STUDIES; FEMALE; FOLLOW-UP STUDIES; HEPATIC ARTERY; HUMANS; INFUSIONS, INTRA-ARTERIAL; KIDNEY; LENGTH OF STAY; LIVER; LIVER DISEASES; LIVER FAILURE, ACUTE; LIVER NEOPLASMS; MALE; MIDDLE AGED; MITOMYCINS; PATIENT SELECTION; PROSPECTIVE STUDIES; REMISSION INDUCTION; SAFETY; SURVIVAL RATE; THROMBOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 1842299850     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Okuda K. Diagnosis and nonsurgical treatment of hepatocellular carcinoma. Hepato-gastroenterol. 1990;37:159-64.
2. Group D'etude et de traitement du carcinome hepatocellulaire. A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma. N Engl J Med 1995;332:1256-61.
3. Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992;163:387-94.
4. Martin M, Tarara D, Wu YM, et al. Intrahepatic arterial chemoembolization for hepatocellular carcinoma and metastatic neuroendocrine tumors in the era of liver transplantation. Am Surg 1996;62:724-32.
5. Harada T, Matsuo K, Inoue T, et al. Is preoperative hepatic arterial chemoembolization safe and effective for hepatocellular carcinoma? Ann Surg 1996;224:4-9.
6. Ouchi K, Matsubara S, Fukuhara K, et al. Recurrence of hepatocellular carcinoma in the liver remnant after hepatic resection. Am J Surg 1993;166:270-3.
7. Lehnert T, Herfarth C. Chemoembolization for hepatocellular carcinoma: What, when, and for whom? Ann Surg 1996;224: 1-3.
8. Okuda K, Ohtsuki T, Obata H, et al. Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Cancer 1985;56:918-28.